Mitchell P. Kopin 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-11 07:24 am Sale | 2021-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Mitchell P. Kopin | 34,597 2.500% | -27,631![]() (-44.40%) | Filing |
2021-01-29 06:23 am Purchase | 2020-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Mitchell P. Kopin | 62,229 6.800% | 50,000![]() (+408.88%) | Filing |
2020-04-24 4:14 pm Purchase | 2020-04-15 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Mitchell P. Kopin | 12,229 5.900% | 12,229![]() (New Position) | Filing |